Skip to main content
Paul Rosenberg, MD, Psychiatry, Baltimore, MD, Johns Hopkins Bayview Medical Center

PaulBRosenbergMD

Psychiatry Baltimore, MD

Geriatric Psychiatry

Associate Professor of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine; Associate Director, Memory and Alzheimer''s Treatment Center Division of Geriatric Psychiatry and Neuropsychiatry

Dr. Rosenberg is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Rosenberg's full profile

Already have an account?

Summary

  • Dr. Paul Rosenberg is a psychiatrist in Baltimore, MD and is affiliated with Johns Hopkins Bayview Medical Center. He received his medical degree from University of Maryland School of Medicine and has been in practice 32 years. He specializes in geriatric psychiatry and is experienced in depression, delirium, and dementa. He has > 130 peer-reviewed publications. He is currently recruiting for trials of escitalopram and THC for agitation in Alzheimer's, psilocybin for depression in mild cognitive impairment, and trazodone for sleep and cognition in mild cognitive impairment.

Education & Training

  • Massachusetts General Hospital/McLean Hospital
    Massachusetts General Hospital/McLean HospitalResidency, Psychiatry, 1990 - 1991
  • Tufts Medical Center
    Tufts Medical CenterResidency, Psychiatry, 1988 - 1990
  • Boston University Medical Center
    Boston University Medical CenterInternship, Internal Medicine, 1985 - 1986
  • University of Maryland School of Medicine
    University of Maryland School of MedicineClass of 1985
  • Harvard University
    Harvard UniversityBA, Magna Cum Laude, 1979

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1991 - 2025
  • MA State Medical License
    MA State Medical License 1986 - 2005
  • American Board of Psychiatry and Neurology Psychiatry

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
  • Paul Beeson Scholar American Foundation for Aging Research, AFAR, 2008

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Effect of Depth of Sedation in Older Patients Undergoing Hip Fracture Repair on Postoperative DeliriumThe STRIDE Randomized Clinical Trial  
    Frederick E Sieber, Allan Gottschalk, Karin J Neufeld, Simon C Mears, Erik A Hasenboehler, Esther S Oh, Mahmood Jaberi, George E Bigelow, Paul B Rosenberg, JAMA
  • Neuropsychiatric Symptoms in Alzheimer's Disease: What Might Be Associated Brain Circuits?  
    Rosenberg PB, Nowrangi MA, Lyketsos CG, Molecular Aspects of Medicine, 1/1/2015
  • Effect of Medications on Physical Function and Cognition in Nursing Home Residents with Dementia  
    Dutcher SK, Rattinger GB, Langenberg P, Chhabra PT, Liu X, Rosenberg PB, Leoutsakos JM, Simoni-Wastila L, Walker LD, Franey CS, Zuckerman IH, J Am Geriatr Soc, 1/13/2014
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Lectures

  • Primary and Secondary Prevention of Alzheimer's Disease 
    Baltimore, MD - 1/27/2014
  • Development of treatments for depression in Alzheimer's Disease 
    Baltimore, MD - 1/8/2014
  • Clinical Trial Challenges in the Study of Age-related Cognitive Disorders 
    1/19/2013
  • Join now to see all

Other

  • Emerging Imaging and Therapeutics in Alzheimer's Disease: Early Detection and Intervention 
    Videotaping for Future Webcast on Medscape Spotlight, Sponsored by Vindico Medical Education
    Boston MA - 1/14/2013
  • Clinical Conversations in Alzheimer's Disease 
    JHU CME for Webcast
    1/2/2013
  • Clinical Conversations in Alzheimer's Disease: Exploring the Diagnostic and Therapeutic Frontier 
    Webinar CME
    1/1/2013

Press Mentions

  • Depression Synergy with Amyloid and Increased Risk of Cognitive Decline in Preclinical Alzheimer Disease
    Depression Synergy with Amyloid and Increased Risk of Cognitive Decline in Preclinical Alzheimer DiseaseAugust 16th, 2019
  • 8 Myths About Dementia You Shouldn’t Believe
    8 Myths About Dementia You Shouldn’t BelieveOctober 24th, 2018
  • Antidepressant Holds Promise in Treating Alzheimer's Agitation
    Antidepressant Holds Promise in Treating Alzheimer's AgitationFebruary 18th, 2014
  • Join now to see all

Grant Support

  • Diads-3: An RCT Of Venlafaxine For Depression In ADNational Institute On Aging2011
  • The Role Of STIM1 In Cardiac And Skeletal Muscle FunctionNational Heart, Lung, And Blood Institute2009–2011
  • PET Imaging Of Activated Microglia In Alzheimer'S DiseaseNational Institute On Aging2008–2011
  • Apathy In Alzheimer'S Disease Methylphenidate TrialNational Institute On Aging2009–2010

Hospital Affiliations